Under the acquisition, Merck‘s wholly subsidiary Monarch Transaction has merged with and into Inspire by making Inspire a wholly subsidiary of Merck.
Merck Neuroscience and Ophthalmology senior vice president and general manager Beverly Lybrand said the completion of the transaction strengthens their ophthalmology business and positions the company for future growth with an expanded portfolio and a best in class commercialization organization.